258 related articles for article (PubMed ID: 33285408)
1. Covalent peptides and proteins for therapeutics.
Berdan VY; Klauser PC; Wang L
Bioorg Med Chem; 2021 Jan; 29():115896. PubMed ID: 33285408
[TBL] [Abstract][Full Text] [Related]
2. Developing Covalent Protein Drugs via Proximity-Enabled Reactive Therapeutics.
Li Q; Chen Q; Klauser PC; Li M; Zheng F; Wang N; Li X; Zhang Q; Fu X; Wang Q; Xu Y; Wang L
Cell; 2020 Jul; 182(1):85-97.e16. PubMed ID: 32579975
[TBL] [Abstract][Full Text] [Related]
3. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
4. Bioconjugation - using selective chemistry to enhance the properties of proteins and peptides as therapeutics and carriers.
Gunnoo SB; Madder A
Org Biomol Chem; 2016 Sep; 14(34):8002-13. PubMed ID: 27461374
[TBL] [Abstract][Full Text] [Related]
5. Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions.
Li L; Liu S; Luo Y
Eur J Med Chem; 2024 May; 271():116394. PubMed ID: 38643668
[TBL] [Abstract][Full Text] [Related]
6. Modulating protein-protein interactions: the potential of peptides.
Nevola L; Giralt E
Chem Commun (Camb); 2015 Feb; 51(16):3302-15. PubMed ID: 25578807
[TBL] [Abstract][Full Text] [Related]
7. The expanding repertoire of covalent warheads for drug discovery.
Mehta NV; Degani MS
Drug Discov Today; 2023 Dec; 28(12):103799. PubMed ID: 37839776
[TBL] [Abstract][Full Text] [Related]
8. Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.
Hermann MR; Pautsch A; Grundl MA; Weber A; Tautermann CS
J Comput Aided Mol Des; 2021 Apr; 35(4):531-539. PubMed ID: 33015740
[TBL] [Abstract][Full Text] [Related]
9. Target identification of covalently binding drugs by activity-based protein profiling (ABPP).
Pichler CM; Krysiak J; Breinbauer R
Bioorg Med Chem; 2016 Aug; 24(15):3291-303. PubMed ID: 27085673
[TBL] [Abstract][Full Text] [Related]
10. Software-aided approach to investigate peptide structure and metabolic susceptibility of amide bonds in peptide drugs based on high resolution mass spectrometry.
Radchenko T; Brink A; Siegrist Y; Kochansky C; Bateman A; Fontaine F; Morettoni L; Zamora I
PLoS One; 2017; 12(11):e0186461. PubMed ID: 29091918
[TBL] [Abstract][Full Text] [Related]
11. bioTCIs: Middle-to-Macro Biomolecular Targeted Covalent Inhibitors Possessing Both Semi-Permanent Drug Action and Stringent Target Specificity as Potential Antibody Replacements.
Yang J; Tabuchi Y; Katsuki R; Taki M
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834935
[TBL] [Abstract][Full Text] [Related]
12. Binding Mode Prediction and Virtual Screening Applications by Covalent Docking.
Scarpino A; Ferenczy GG; Keserű GM
Methods Mol Biol; 2021; 2266():73-88. PubMed ID: 33759121
[TBL] [Abstract][Full Text] [Related]
13. Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction.
Sillerud LO; Larson RS
Curr Protein Pept Sci; 2005 Apr; 6(2):151-69. PubMed ID: 15853652
[TBL] [Abstract][Full Text] [Related]
14. The Medicinal Chemistry of Therapeutic Peptides: Recent Developments in Synthesis and Design Optimizations.
Parthasarathy A; Anandamma SK; Kalesh KA
Curr Med Chem; 2019; 26(13):2330-2355. PubMed ID: 29022499
[TBL] [Abstract][Full Text] [Related]
15. Interfering peptides targeting protein-protein interactions: the next generation of drugs?
Bruzzoni-Giovanelli H; Alezra V; Wolff N; Dong CZ; Tuffery P; Rebollo A
Drug Discov Today; 2018 Feb; 23(2):272-285. PubMed ID: 29097277
[TBL] [Abstract][Full Text] [Related]
16. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
Seebach D; Beck AK; Bierbaum DJ
Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
[TBL] [Abstract][Full Text] [Related]
17. Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal.
Martín-Gago P; Olsen CA
Angew Chem Int Ed Engl; 2019 Jan; 58(4):957-966. PubMed ID: 30024079
[TBL] [Abstract][Full Text] [Related]
18. Targeting recognition surfaces on natural proteins with peptidic foldamers.
Checco JW; Gellman SH
Curr Opin Struct Biol; 2016 Aug; 39():96-105. PubMed ID: 27390896
[TBL] [Abstract][Full Text] [Related]
19. Drug bioactivation, covalent binding to target proteins and toxicity relevance.
Zhou S; Chan E; Duan W; Huang M; Chen YZ
Drug Metab Rev; 2005; 37(1):41-213. PubMed ID: 15747500
[TBL] [Abstract][Full Text] [Related]
20. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
Gehringer M; Laufer SA
J Med Chem; 2019 Jun; 62(12):5673-5724. PubMed ID: 30565923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
